I've followed CRISPR trials for three years, and the latest results on sickle cell are genuinely impressive. Yet the same technology that edits disease out of embryos could be used to select for height or IQ, and that line keeps blurring. Should we restrict germline editing to therapeutic uses only, or is that just a slippery slope we're already on?